Globus Medical Preps IPO, Sales Force Ramp Ahead Of Artificial Cervical Disc Approval
This article was originally published in The Gray Sheet
Executive Summary
Firm files for initial public stock offering, awaits PMA approval of its Secure-C artificial cervical disc.
You may also be interested in...
Financings In Brief
Globus Medical goes public. Exact Sciences nets $57.8 million from stock sale for cancer test. Cleveland Heart gets $30 million for artificial heart development. More financings.
New Guidance Outlining Total Artificial Disc Trial Design Issued
Investigational device exemption applications for total artificial disc systems should include plans for product durability testing and multi-center clinical trials with at least two years of follow-up, according to new FDA guidance
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.